Navigation Links
Ottawa researcher named 2013 Champion of Genetics
Date:5/8/2013

May 8, 2013, Victoria BC - The Canadian Gene Cure Foundation (CGCF), a national, charitable foundation committed to enabling Canadians to lead the world in the discovery and advancement of cures for inherited diseases, has honoured Dr. Alex MacKenzie by naming him a 2013 Champion of Genetics.

The CGCF Champion of Genetics award both honours the work of Canada's established scientists and provides support, inspiration and encouragement to bright young researchers in the early years of their careers.

This year, the CGCF Champions of Genetics nominating committee has honoured Dr. MacKenzie, along with four other scientists, for the significant contribution they have made in translational research. The chosen Champions also must be active mentors with a history of encouraging and enabling students in the field of genetics, and they must be active researchers, continuing to contribute to the Canadian genetics community.

CGCF Board Chair Sandra MacPherson said: "The CGCF Champions of Genetics are highly regarded both at home in Canada, and internationally. Not only are they excellent role models for aspiring young scientists, they are also continuing to work on the forefront of discoveries in the field of genetics. With the focus this year on translational medicine, CGCF is proud to be honouring scientists that have taken their work out of the lab and into patient care. They are Champions in the research community and also to the many families they have helped through their work."

Alex MacKenzie is principal investigator of the Apoptosis Research Centre at the Children's Hospital of Eastern Ontario and a professor in the Department of Pediatrics at the University of Ottawa. Dr. MacKenzie and his team have focused their research on inherited disorders and orphan diseases in children, identifying gene subsets for three disorders Duchenne muscular dystrophy, myotonic dystrophy, and spinal muscular atrophy (SMA). Dr. MacKenzie is a specialist in the field of SMA, a fatal neurodegenerative disease that often ends lives before age two.

"Our Champions are playing a crucial role in maintaining the reputation of Canada as a world leader in the field of genetics and molecular genomics," said CGCF board member Dr. Anny Fortin. "Dr. MacKenzie's involvement as a research scientist, medical doctor, advocate and spokesperson for the cause of spinal muscular atrophy (FightSMA) makes him one of the greatest examples of knowledge translation in Canada."

As part of the honour of being named a Champion of Genetics, Dr. MacKenzie was given the opportunity to nominate an individual he has personally mentored to apply for a $90,000 Champions of Genetics: Building the Next Generation Grant. The grant, made possible with the help of our funding partner the CIHR- Institute of Genetics, will provide much needed funding for the chosen young scientists. It will provide them the opportunity to advance their own exciting genetic research and discoveries and to mentor yet the next generation of scientists, perpetuating Canada's level of excellence in genetic research.

Also honoured by the Canadian Gene Cure Foundation along with Dr. MacKenzie were:

Dr. Bartha Knoppers, Canada Research Chair in Law and Medicine at McGill University; Director of the Centre of Genomics and Polity, Faculty of Medicine, Department of Human Genetics; Chair of the Ethics Working Party of the International Stem Cell Forum; Co-Chair of the Sampling/ELSI Committee of the 1000Genomes Project and a Member of the Scientific Steering Committee of the International Cancer Genome Consortium.

Dr. Steven Narod, Senior Scientist, Women's College Research Institute; Director, Familial Breast Cancer Research Unit, Women's College Research Institute; Professor, Dalla Lana School of Public Health, University of Toronto; Professor, Department of Medicine, University of Toronto; Tier 1 Canada Research Chair in Breast Cancer.

Dr. Alexey Pshezhetsky, Professor, Dept. of Pediatrics and Biochemistry, University of Montreal; Researcher, Dept. of Medical Genetics, Ste-Justine Hospital Research Center; Scientific Director of Medical Genetics Diagnostic Laboratory and Director of the Lysosomal Biology lab at Ste-Justine Hospital Research Center.

Dr. David S. Rosenblatt, professor of Human Genetics, Medicine, Pediatrics, and Biology at McGill University in Montral and chair of the university's Department of Human Genetics for the past 11 years. He is a Fellow of the Canadian Academy of Health Sciences and a Correspondant tranger of the Acadmie Nationale de Mdecine of France.


'/>"/>

Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute
Source:Eurekalert

Related medicine news :

1. Paul McCartney Tickets: Paul McCartney Tickets in Kanata Ottawa at the Scotiabank Place Go on Sale on Friday, April 26th at 10:00 a.m. Local Time
2. TEAL Ottawa Launches Skin Imperfection Treatments by Thermo LO
3. Don’t Compromise Your Health, Ottawa Residents!
4. Duke researchers describe how breast cancer cells acquire drug resistance
5. McAdams DeMarco Awarded $100,000 as First Arthritis-Aging Collaborative Researcher
6. CWRU School of Medicine researchers discover new target for personalized cancer therapy
7. U of M researchers discover link between heart, blood, and skeletal muscle
8. Researchers determine where best to place defibrillators
9. Researchers plot locations where AEDs could save more lives
10. Gene Mutation Linked to Migraines, Researchers Say
11. Discovery of New Cause of Congenital Hydrocephalus Opens the Door to Collaborative Research Study, Hydrocephalus Association Commends Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... ... The annual time frame to change Medicare health and prescription drug coverage, known ... Medicare beneficiaries who are looking to switch from their current plan to a Medicare ... during this period order for their new policy to go into effect in 2017. ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs available ... must find the one that works for them. When an inventor from Suisun City, ... worked and decided to share it with others. , He developed a prototype for ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to announce ... covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients ... life 6 years in the last 3 decades,” says Dr. Valentine Fuster, a ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
(Date:12/2/2016)... LYME, Conn. , Dec. 1, 2016  Today, ... has announced the honor of being selected as winners ... include: Simpson Healthcare Executives Website at the PLATINUM level, ... Conversations Training Module at the GOLD Level, and our ... At Simpson Healthcare Executives, we are excited ...
(Date:12/2/2016)... YORK , December 2, 2016 ... of its past losses following Trump,s victory early in ... potential, and fund managers are now predicting an uptick ... at four equities to see how they have fared ... CLDX ), Amicus Therapeutics Inc. (NASDAQ: ...
Breaking Medicine Technology: